Skip to main content

Table 2 Distribution of multidrug–resistance among isolates of colonized patients

From: Influx of multidrug-resistant organisms by country-to-country transfer of patients

Species

No. (%) of isolates

No. (%) of MDR–GN

No. (%) XDR–GN

No. and type of Carbapenemase in XDR–GN

Escherichia coli

42 (40.4)

39 (65)

3 (21.4)

1 none

1 NDM–1

1 KPC

MRSA

18 (17.3)

N/A

N/A

N/A

Klebsiella pneumoniae

18 (17.3)

14 (23.3)

4 (28.6)

2 none

1 NDM–1

1 OXA–48

VRE (all E. faecium)

12 (11.5)

N/A

N/A

N/A

Pseudomonas aeruginosa

6 (5.8)

3 (5)

3 (21.4)

2 none

1 VIM–1

Acinetobacter baumanii

3 (2.9)

0 (0)

3 (21.4)

3 OXA–23

Enterobacter cloacae

3 (2.9)

2 (3.3)

1 (7.1)

1 VIM–4

Proteus mirabilis

1 (1.0)

1 (1.7)

0 (0)

N/A

Klebsiella oxytoca

1 (1.0)

1 (1.7)

0 (0)

N/A

total

104 (100)

60 (100)

14 (100)

9

  1. N/A not applicable, MRSA methicillin–resistant Staphylococcus aureus, VRE vancomycin–resistant Enterococci, NDM–1 New Delhi metallo–beta–lactamase 1, KPC Klebsiella pneumoniae carbapenemase, OXA–23/48 oxacillinase group beta–lactamase 23/48, VIM–1/4 Verona integron–encoded metallo–beta–lactamase 1/4